Nice rise in share price Friday.
Our half-yearly is out Thursday and that will be interesting. The quarterly last month suggested the likelihood of 'no dividend' but it was not absolutely dismissed. Our formula would allow about 3c for the dividend but it may be more prudent to retain the cash given the lithium pricing lately.
Thursday will tell us whether management are confident there will be an upturn in prices (dividend payable) or whether they expect the low pricing to continue a while yet.
- Forums
- ASX - By Stock
- PLS
- Good News & Bad News
Good News & Bad News, page-38663
Featured News
Add PLS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.09 |
Change
0.130(4.39%) |
Mkt cap ! $9.290B |
Open | High | Low | Value | Volume |
$3.05 | $3.14 | $3.01 | $61.02M | 19.76M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
40 | 187380 | $3.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.10 | 340675 | 48 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
82 | 337569 | 3.090 |
26 | 107655 | 3.080 |
17 | 264658 | 3.070 |
10 | 263179 | 3.060 |
11 | 78266 | 3.050 |
Price($) | Vol. | No. |
---|---|---|
3.100 | 325590 | 49 |
3.110 | 101441 | 12 |
3.120 | 157723 | 22 |
3.130 | 196734 | 20 |
3.140 | 315730 | 32 |
Last trade - 15.54pm 12/11/2024 (20 minute delay) ? |
Featured News
PLS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online